Masterlongevity,
Although only a lurker on this board (I came because of DD and GTCB), I am a long time holder and studier of Élan and their drugs. Could you delve a bit deeper into why you feel that Ty has a "diminished potential"?
While the uptake is slower than many had thought, it was fairly clear that the neuros would be twice as careful this time around.
Having several friends with MS, I have seen first hand the efficacy of Ty. I truly believe that the scripts will be patient driven as more and more patients see for themselves the improvements Ty can provide.
Regards,
Cat
Market Data 
Markets 
AI
